← Back to Search

Behavioral Intervention

Sign Language Instruction for Deafness

N/A
Recruiting
Led By Leala Holcomb, PhD
Research Sponsored by The University of Tennessee, Knoxville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from enrollment to the end of treatment 9 academic months later.

Summary

This trial will involve teachers who will be split into two groups - one group will receive training to help deaf children learn sign language, while the other group will continue with their usual teaching methods. The study will assess the progress of deaf children at the beginning and end of the school year.

Who is the study for?
This trial is for deaf children in prekindergarten to 3rd grade and their teachers. The study aims to include those involved in deaf education programs, specifically targeting educators teaching these grades.
What is being tested?
The study tests a new method called Strategic and Interactive Signing Instruction (SISI) against the standard 'business-as-usual' teaching methods. Teachers will be split into two groups: one receiving SISI training and the other continuing with current practices.
What are the potential side effects?
Since this trial involves educational strategies rather than medical interventions, there are no traditional side effects. However, potential impacts could include changes in sign language development or teaching effectiveness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from enrollment to the end of treatment 9 academic months later.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from enrollment to the end of treatment 9 academic months later. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Sign Language Skills
Teacher Practice
Secondary study objectives
Written Language Skills

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Quasi-Experimental Study - ExperimentalExperimental Treatment1 Intervention
This quasi-experimental study involves teachers divided into an experimental group and a control group. Teachers in the experimental group will receive SISI training to support the sign language development of deaf children, while those in the control group will continue with "business-as-usual" teaching methods. Pre- and post-assessments will be conducted for all deaf children at the beginning and end of the school year.
Group II: Quasi-Experimental Study - ControlPlacebo Group1 Intervention
This quasi-experimental study involves teachers divided into an experimental group and a control group. Teachers in the experimental group will receive SISI training to support the sign language development of deaf children, while those in the control group will continue with "business-as-usual" teaching methods. Pre- and post-assessments will be conducted for all deaf children at the beginning and end of the school year.

Find a Location

Who is running the clinical trial?

The University of Tennessee, KnoxvilleLead Sponsor
90 Previous Clinical Trials
19,064 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
361 Previous Clinical Trials
181,908 Total Patients Enrolled
41 Trials studying Deafness
38,398 Patients Enrolled for Deafness
Leala Holcomb, PhDPrincipal InvestigatorCenter of Deafness
1 Previous Clinical Trials
4 Total Patients Enrolled
~100 spots leftby Jul 2026